胥洋副研究员团队在GLP-1受体激动剂对2型糖尿病患者心力衰竭住院风险影响研究方面取得进展
北京大学药学院药事管理与临床药学系
The research team of Prof. Yang Xu has made progress in the study of the impact of GLP-1 receptor agonists heart failure hospitalization risk in type 2 diabetes patients
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2026, (7): 690
-691
.
>
>